1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed guidelines
for treating patients with acute limb ischaemia (ALI). The focus on the guidelines is on lower …

Open bypass surgery remains a major tool for limb salvage in chronic limb-threatening
ischemia (CLTI). Although rest pain and tissue loss both fall into the category of CLTI, goals …

Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular
disease down to lower extremity artery disease, from subclinical to disabling symptoms and …

Introduction: Thrombogenesis, a major cause of implantable cardiovascular device failure,
can be addressed through the use of biodegradable polymers modified with anticoagulating …

Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular
disease down to lower extremity artery disease, from subclinical to disabling symptoms and …

Objective/Background In critical limb ischaemia (CLI), current guidelines recommend
revascularisation whenever possible, preferentially through endovascular means. However …

Dual-antiplatelet therapy is commonly prescribed after endovascular intervention for
peripheral artery disease. However, it is not known whether therapeutic anticoagulation …

Objective No consensus has yet been reached regarding the optimal antiplatelet and
anticoagulant regimen for patients after lower extremity bypass. Usually, patients who have …

Background Antiplatelet monotherapy is recommended after infrainguinal lower extremity
bypass (LEB). However, there is a paucity of high-quality data to guide therapy, and …

Background In patients undergoing revascularization for peripheral arterial disease (PAD),
low-dose Factor Xa inhibitors (FXaI) taken with aspirin improved limb and cardiovascular …